Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
5-Amino-1MQ: Evidence Summary
Evidence summary for 5-Amino-1MQ across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to 5-Amino-1MQ overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Fat metabolism / obesity | Tier D | 0 | NNMT inhibition reduces fat mass in mouse models; zero human data |
| NNMT inhibition | Tier D | 0 | Mechanism well-characterized in vitro; no human clinical data exists |
References (2)
- Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction. . Diabetes, obesity & metabolism (2024) PMID: 39161060
- Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice. — Dimet-Wiley A, Wu Q, Wiley JT, et al. . Scientific reports (2022) PMID: 35013352